Skip to main content
Equibles
MBIO logo

MBIO · Mustang Bio, Inc. · Metrics

Track MBIO — free

Use MBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.38 0.00 (-0.76%)
Rebalance outlook locked
Market Cap
$2.90M
Shares
7.58M
Volume · Oct 21 29.22K Avg daily vol (3M) 31.9K

MBIO metrics

57 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.38
Market cap
$2.90M

Price action

20 metrics
Price change (1W)
+3.4%
Price change (30D)
-30.4%
Price change (3M)
-35.2%
Price change (6M)
-50.0%
Price change (YTD)
-61.0%
Price change (1Y)
-75.3%
Trailing year
Price change (5Y)
—
52-week high
$1.55
52-week low
$0.37
Change from 52-week high
-75.3%
Change from 52-week low
+3.4%
Annualized volatility
64.6%
Annualized volatility (3M)
55.9%
Beta
1.3
RSI (14D)
31.0
Price vs SMA 50
-23.7%
Price vs SMA 200
-46.3%
Avg volume (3M)
31,888
Relative volume
0.9
Average dollar volume
$16,180

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
7.58M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.4
reciprocal yield 262.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-105.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2021-08-16

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$3.52M
Net income (TTM)
−$3.03M
Trailing 12 months
Diluted EPS (TTM)
$-0.45
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-0.53
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.46
Operating cash flow per diluted share (TTM)
$-0.69
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.01
Book value per share
$453.30

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+67.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-40.2%
Return on assets
-19.4%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$15.15M
Total assets
$15.61M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$4.51M
Capital expenditures (TTM)
—
R&D (TTM)
$7.56M
SG&A (TTM)
—
Stock compensation (TTM)
$89,000
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
23
13F filer change QoQ
+1
Institutional ownership
7.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+29.9%
Holder tenure
5.9
Price vs estimated holder cost
-40.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.5%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
38 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1680048 CUSIP 62818Q302 Visit website Investor relations